Intelligent Health organizes a healthtech summit that connects clinicians, technologists, and executives to discuss the use of AI in medicine. The summit aims to advance conversations and collaboration in the healthcare sector, focusing on innovations and solutions in health technology.

Intelligent Health

Activ Surgical is involved in the development of surgical technologies and tools. Self-described as innovative, it focuses on enhancing surgical procedures through its technological offerings.

Activ Surgical

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Asensus Surgical, Inc.

Auris Health develops the MONARCH™ Platform, a flexible robotic platform cleared for use in bronchoscopy and urology procedures, aimed at uncovering treatment pathways to improve patient care.

Auris Health

Intelligent Health AI | 9,656 followers on LinkedIn. The world&#39;s leading AI in medicine summit series. Next event: 11th  -12th September 2024, Basel Switzerland | Intelligent Health AI gathers the global AI and health community to progress discussion about how AI can be used to prevent and solve some of the world’s greatest healthcare problems, improve the health of the human race, and set the global AI agenda in healthcare. Upcoming events: 13-14 September 2023 in Basel, Switzerland

Founder & CEO @ InspiredMinds! | World Summit AI | United Nations Advisor AI | Ambassador Women & Girls | Endurance Swimmer 🏊♀️ | ♥️Endurance…

Sarah Porter

UCLA & RIT Alumni🎓 US Government Scholar📚 Marketing, Sales & Delegate Strategy Executive📈 and…

Diellza Rifati

Intelligent Health AI

“A word about my personal philosophy. It is anchored in optimism. It must be, for optimism brings with it hope, a future with a purpose, and therefore, a will to fight for a better world. Without this optimism, there is no reason to carry on. If we think of the struggle as aclimb up a mountain, then we must visualize a mountain with no top. We see a top, but when we finally reach it, the overcast rises and we find ourselves merely on a bluff. The mountain continues on up. Now we see the "real" top ahead of us, and strive for it, only to find we've reached another bluff, the top still above us. And so it goes on, interminably. Knowing that the mountain has no top, that it is a perpetual quest from plateau to plateau, the question arises, "Why the struggle, the conflict, the heartbreak, the danger, the sacrifice. Why the constant climb?" Our answer is the same as that which a real mountain climber gives when he is asked why he does what he does. "Because it's there." Because life is there ahead of you and either one tests oneself in its challenges or huddles in the valleys of a dreamless day-to-day existence whose only purpose is the preservation of a illusory security and safety. The latter is what the vast majority of people choose to do, fearing the adventure into the known. Paradoxically, they give up the dream of what may lie ahead on the heighs of tomorrow for a perpetual nightmare - an endless succession of days fearing the loss of a tenuous security.” Saul Alinsky, Rules for Radicals: A Pragmatic Primer for Realistic Radicals 🖤 #womensrights #publichealth #optimism

Intelligent Health AI is the world’s leading – and largest – AI in medicine summit. Since 2017, we have cultivated the world's largest and leading healthtech community committed to saving lives with AI. This year's agenda will stage high-level conversations with leading key voices, showcasing the very latest use cases, advancements and innovations in diagnostic pathways and treatment; paving the way towards a positive healthcare future that is powered by ethical, equitable and safe AI. But don’t just take it from us. Here’s what some of our esteemed #HealthTech and #AICommunity have to say 👇 Applications for #IH24 are open now. So what are you waiting for? Join us in Basel on 11–12 September. Take your chance to stand amongst the AI in healthcare giants and see how we do health. 🎟️ ⇢ https://hubs.li/Q02DMrgV0 🗣️ ⇢ https://hubs.li/Q02DMr1V0 #IH24 #IntelligentHealth #SaveLivesWithAI #DoAIDifferent

Revolutionizing lung cancer diagnosis with AI! 🚀 A new digital pathology platform developed by researchers at the University of Cologne is set to enhance lung cancer diagnosis through advanced AI algorithms. This cutting-edge tool enables faster, more accurate analysis of tissue samples, promising significant advancements in personalized treatment options. Discover how AI is transforming the fight against one of the deadliest cancers! Read more here ⇢ https://hubs.li/Q02MKBZv0 #DigitalPathology #AIinHealthcare #LungCancerAwareness #MedicalInnovation #TechInMedicine #FutureOfDiagnosis #PathologyInnovation #AIRevolution #HealthTech

Total pleasure having Airia - Enterprise AI Simplified at #IH24 today sharing their insights #IH24 #SaveLivesWithAI #HealthcareAI 😍🧠

There needs to be a good split between transformational experiences and taking users on a journey through new Gen AI models Antonio Russo, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte

"You can't leave the human element. There is a critical component to this, specifically with chronic disease. There is a litany of misinformation out there which makes things very challenging for the patient. The life science communities have done an amazing job of patience within market access and support to those struggling - AI can provide a unique experience in a personalised journey but the human touch cannot be lost" Chris Guyer, Group Vice President for North America and Europe, RxPx #IH24 #SaveLivesWithAI #HealthcareAI

🌍 New Partnership Advancing Prostate Cancer Diagnostics in the Middle East! Nanostics and OncoHelix have joined forces to bring ClarityDX Prostate—an AI-powered, blood-based diagnostic tool—to healthcare providers and men across the Middle East. This cutting-edge technology is a game-changer for those at risk of aggressive prostate cancer, offering data-driven risk assessments to support critical healthcare decisions. With OncoHelix’s state-of-the-art OncoHelix-coLAB facility at Burjeel Medical City, Abu Dhabi, healthcare providers will now be able to leverage ClarityDX Prostate to improve early detection, empower treatment, and ultimately enhance patient outcomes. This partnership between two Alberta-based companies shows the global impact of AI and precision health technologies, revolutionizing how we approach cancer diagnostics and care. Why it matters: AI-Powered Insights: ClarityDX Prostate uses AI-driven learning models to determine the risk of aggressive prostate cancer. Early Detection: Helps identify men who need further diagnostic follow-up, allowing for earlier and more targeted treatments. Cutting-Edge Collaboration: OncoHelix’s laboratory within Burjeel Medical City is a joint venture with Burjeel Holdings, enhancing diagnostic services in the MENA region. 🌍 Prostate cancer is just one area where AI is transforming healthcare. Join us at Intelligent Health Qatar on December 10-11 to dive deeper into how AI is revolutionizing diagnostics and patient care across the region. Be part of the conversation shaping the future of healthcare this December!💡 Read more: https://hubs.li/Q02SjXq00 #AI #HealthcareInnovation #ProstateCancer #PrecisionDiagnostics #ClarityDXProstate #OncoHelix #Nanostics #IntelligentHealth #Qatar #AIHealth

The global healthcare AI market could reach $614bn within a decade 📈 The future of healthcare is AI-driven, and this latest article highlights a staggering prediction: the global healthcare AI market is set to soar to $614 billion by 2033 📈 This growth reflects the increasing demand for AI in healthcare, including predictive analytics, robotic surgeries, and personalised treatment plans. 🔗 Read more about the key factors driving this growth and the innovations shaping the future of healthcare here: https://hubs.li/Q02R-MQv0 #HealthcareAI #ArtificialIntelligence #DigitalHealth #AIFuture

🌟 The Future of Mental Health Care is Here! 🌟 AI-driven mental health apps are revolutionizing the way we provide care, making support more accessible, personalized, and efficient than ever before. From AI-powered chatbots offering real-time empathy to apps analyzing medical records for accurate diagnoses, these innovations are bridging the gap caused by the global shortage of mental health professionals. Read more 👀 https://hubs.li/Q02RQ7g50 #IntelligentHealth #SaveLivesWithAI #AIForGood #MentalHealth

India’s National Health Authority and Indian Institute of Technology Kanpur are creating an AI benchmarking platform using Ayushman Bharat Digital Mission (ABDM) data to improve disease diagnosis and public health outcomes. This initiative will help validate AI models and democratize access to quality healthcare. 🚀💡 Read more: https://hubs.li/Q02R2L_r0 #IntelligentHealth #SaveLivesWithAI #AIForGood #AIRegulation

Metric
Company Name	Intelligent Health	Activ Surgical	Asensus Surgical, Inc.	Auris Health
Symbol			ASXC
MSH ID	AI:INTELLIGENTHEALTH	COM:ACTIVSURGICAL	COM:ASENSUS	COM:AURISHEALTH
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Health Technology	Medical Devices	Medical - Devices	Medical Devices
Country	CH	US	US	US
Stage
Employee Count			207
Website	intelligenthealth.ai	activsurgical.com	asensus.com	aurishealth.com
LinkedIn	intelligent-health-ai-ltd
Founders

Metric
Market Cap		91.27M
Enterprise Value
Monthly Web Traffic	1.45K
Web Traffic Growth	-0.76
Valuation
Raised Capital

Metric
Revenue			8.58M
Revenue (LTM)
Revenue (NTM)
Gross Profit			-5.03M
EBITDA			-74.40M
Operating Income			-78.13M
Net Income			-78.43M
EPS			-0.31
Diluted EPS			-0.31
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			-0.34
Operating Profit Margin			-7.22
EBITDA Margin			-8.67
Net Profit Margin			-8.51
Return on Equity			-1.10
Return on Assets			-1.12
Return on Capital Employed			50.15

INTE

AI:INTELLIGENTHEALTH

Intelligent Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-0.84
P/B Ratio			1.40
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			11.84
EV Multiple			-0.87

Metric
Days Sales Outstanding			43.07
Days Payables Outstanding			147.66
Days Inventory Outstanding			218.03
Operating Cycle			346.59
Cash Conversion Cycle			232.56
Asset Turnover			0.26

Metric
Operating Cash Flow			-63.63M
Free Cash Flow			-64.19M
Cash Flow to Debt			-2.77
Operating Cash Flow/Sales			-5.75
Free Cash Flow Yield			-0.95

Metric
Cash & Equivalents			17.10M
Accounts Receivable			-1.18M
Inventory			7.17M
Goodwill
Debt to Capitalization			2.24
Debt to Assets			0.08
Current Ratio			3.79
Quick Ratio			2.78

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			1.42
R&D to Revenue			6.58
SG&A to Revenue			3.56